GLP-1 Samples
GLP-1 Samples is reader-supported. We may earn a commission when you start a consult through one of our links — never paid for placement. Full disclosure
Provider review · Reviewed 2026-05-04 · GLP-1 Samples Editorial Team

Mochi Health Review 2026: PA Specialists for Wegovy & Zepbound

Mochi Health specializes in prior-authorization handling for GLP-1 medications. $99-199/month platform fee + insurance-covered medication ($25-150 copay typical). Best fit for commercially insured patients prioritizing brand-name Wegovy/Zepbound.

What Mochi Health does well

Mochi Health's competitive moat is PA expertise. The team has built infrastructure specifically around the documentation patterns that commercial insurance plans require for Wegovy and Zepbound coverage. For patients with commercial insurance and clear BMI eligibility, Mochi often produces faster + more reliable PA outcomes than navigating through primary care.

What Mochi handles well:

When Mochi is the right pick

When Henry Meds or others are better

FAQ

What is Mochi Health?

Mochi Health is a GLP-1-focused telehealth platform that specializes in prior-authorization (PA) handling for Wegovy and Zepbound. The platform's differentiator is the dedicated PA team — they handle the insurance documentation needed to get GLP-1 medications covered through commercial insurance. For patients with commercial insurance + BMI eligibility, Mochi can produce $25/month copay outcomes via the manufacturer savings card path.

How much does Mochi Health cost?

Mochi Health runs $99-199/month for the platform consult + PA handling + ongoing monitoring. The medication cost is separate (covered by insurance after PA, or cash-pay if PA fails). With commercial insurance + savings card, total all-in cost is typically $124-349/month (Mochi platform fee + $25-150 medication copay). Without insurance, Mochi works less well — patients are better served by direct cash-pay paths (LillyDirect, NovoCare, compounded).

Is Mochi Health legitimate?

Yes. Mochi Health is a US-licensed telehealth platform with US-licensed clinicians and dedicated PA + medical operations teams. Strong reputation specifically for insurance-coverage-handling expertise. Mochi specializes in the GLP-1 commercial-insurance landscape rather than competing on cash-pay pricing.

Mochi vs Henry Meds — which is better?

Both are GLP-1 telehealth platforms with PA handling. Mochi specializes more aggressively in commercial-insurance PA outcomes; Henry Meds is broader (handles both insurance + cash-pay paths including compounded). For patients with commercial insurance and clear BMI eligibility, Mochi's PA expertise often produces faster + more reliable insurance coverage. For uninsured or insurance-denied patients, Henry Meds offers more cash-pay alternatives.

Does Mochi do compounded GLP-1?

Mochi's primary focus is brand-name (Wegovy, Zepbound) through insurance coverage. Some patients can access compounded options through the platform, but the brand-coverage path is the main offering. For patients prioritizing compounded ($179/month cash-pay) over brand-with-insurance, dedicated compounded providers (Direct Meds, Henry Meds compounded plan) are typically more efficient.

How fast does Mochi process prior authorization?

Mochi's PA team typically processes initial PA within 1-2 weeks. For approvals: medication ships within days. For denials: appeals process adds 2-4 weeks. Total timeline from intake to first medication: typically 3-5 weeks for insurance-covered path. Faster than navigating PA through your primary care provider; comparable to other dedicated PA telehealth platforms.

Bottom line on Mochi Health

For commercially insured patients prioritizing brand-name Wegovy/Zepbound coverage, Mochi Health's PA expertise is genuinely valuable. $99-199/month platform fee + $25-150 medication copay = $124-349/month all-in for insurance-covered path. Uninsured patients are better served by direct cash-pay alternatives or compounded providers.

Find my best GLP-1 path →